Trial record 2 of 2 for:    FOLFOX plus bevacizumab, assessing tumor blood flow

DCE-MRI PET Bevacizumab Study in Rectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01426074
Recruitment Status : Active, not recruiting
First Posted : August 31, 2011
Last Update Posted : September 26, 2016
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : August 2014
  Study Completion Date : No date given